戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d through increased amounts of ghrelin, a GH stimulator.
2 hile undergoing implantation of a deep brain stimulator.
3 urkholderia thailandensis, are potent immune stimulators.
4 hibitors of transcription into gene-specific stimulators.
5 sis of astrocytomas might be blocked by PKCe stimulators.
6 rease in CpG and UpA dinucleotides as immune stimulators.
7 human-use adjuvant ALFQ that contains immune-stimulators.
8 strikingly different effects depending on co-stimulators.
9 red engaged CD28, ICOS, CD226 and SLAM-F1 co-stimulators.
10 equired the adaptor protein IFNbeta promoter stimulator 1 (IPS-1, MAVS) and could be functionally unc
11 sing NS3/4A and TLR3/MyD88/IFN-beta promoter stimulator 1(-/-) mouse embryonic fibroblasts completely
12 ficiently cleaves TRIF and IFN-beta promoter stimulator 1, adaptors for TLR3 and the RLRs, respective
13 (PKC) pathways, while treatment with the PKC stimulator 12-O-tetradecanoylphorbol-13-acetate restored
14                       One putative autophagy stimulator, 6-phosphofructo-2-kinase/fructose-2,6-biphos
15  of a biofuel cell (BFC) and an animal brain stimulator (ABS) implanted in a pigeon.
16 armacologic long-term treatment with a NO-GC stimulator altered auditory nerve responses but did not
17 igned for neurophysiological studies such as stimulators, amplifiers and recording microelectrodes do
18 hanocarba nucleosides (i.e., compound 3 as a stimulator and compound 8 as a partial inhibitor of P-gp
19 on between expression of inducible T-cell co-stimulator and induction of virus-specific antibodies in
20 lar basis for the mechanism of action of sGC stimulators and suggest the potential therapeutic utilit
21 The co-stimulators ICOS (inducible T cell co-stimulator) and CD28 are both important for T follicular
22 tivated transcutanously using a programmable stimulator, and the resultant finger flexion joint angle
23 al (pH, uric acid, glucose) sensors, thermal stimulators, and humidity energy harvesters.
24 ave been conducted to evaluate the impact of stimulator architecture and geometry on stimuli features
25              Implantable cardiac vagal nerve stimulators are a promising treatment for ventricular ar
26           The results demonstrate that these stimulators are able to deliver osteoconductive stimuli.
27 O generators, a number of sGC activators and stimulators are currently in clinical trials aiming to s
28                   Clinically approved neural stimulators are limited by battery requirements, as well
29                     Bioresorbable electronic stimulators are of rapidly growing interest as unusual t
30                            When warm thermal stimulators are placed on the ring and index fingers of
31 e-scale integration of ultrathin sensors and stimulator arrays in multiple layers.
32  resolves the longstanding question of where stimulators bind and provides a path forward for drug di
33                    These data indicated that stimulators bind to a conserved cleft between two subdom
34                  Using NMR, we also examined stimulator binding to sGC from M. sexta and bacterial H-
35                          The localization of stimulator binding to the sGC heme domain reported here
36 e bulkier tryptophan residues directly block stimulator binding.
37                                 B lymphocyte stimulator (BLyS) engenders survival and antibody secret
38 ion-inducing ligand (APRIL) and B-lymphocyte stimulator (BLyS), are important for the survival, proli
39 design and fabrication of a micro-scale cell stimulator capable of simultaneously providing mechanica
40 administered under general anesthesia, and a stimulator coil consisting of 2 individual cone-shaped c
41 d significantly enhanced responses to OVA(+) stimulators compared to sham-operated controls.
42 photolyzable diazirine derivative of a novel stimulator compound, IWP-051, and MS analysis, we locali
43 e sGC show clinical promise, but where these stimulator compounds bind and how they function remains
44 n's disease (PD) implanted with a deep brain stimulator (DBS) to test the hypothesis that the beta wa
45 ty effort of sharing and developing a common stimulator design for vision research.
46 li distributions were observed for different stimulator designs and different external excitations.
47 cremoris and Lc. lactis subsp. lactis showed stimulator effects (160%).
48 myelinated cochlear nerve fiber coupled to a stimulator-electrode-tissue interface.
49 strate the capability of this general visual stimulator experimentally in the in vitro mouse retinal
50 ith acute HCV infection; inducible T-cell co-stimulator expression correlates with production of HCV-
51 sponse to parasite stimulation, as a rosette-stimulator for Plasmodium falciparum- and P. vivax-IRBC.
52                  CPEC appears to be a potent stimulator for switching the anti-angiogenic SMC phenoty
53 ation as well as a Peltier-based temperature stimulator for thermogenetics.
54 diverse reverse transcriptases can be strong stimulators for slippage at slippage-prone template moti
55                           The 3' part of the stimulator functions largely independently and acts at l
56                                       The co-stimulators ICOS (inducible T cell co-stimulator) and CD
57 stimulatory receptors, with the inducible co-stimulator (ICOS) being most notable.
58 vity but also increased CD3 and inducible co-stimulator (ICOS) expression on T cells.
59 e exposed to Tfh-cell-promoting inducible co-stimulator (ICOS) ligand.
60 eficient ILC2s including inducible T cell co-stimulator (Icos).
61 rkinson's disease (N = 22) during deep brain stimulator implantation surgery (14 females, 18 males).
62 nable stable, long-lived operation as distal stimulators in a rat model of peripheral nerve injuries,
63 ysLTs and their relationship with other ILC2 stimulators in the activation of human ILC2s.
64 guat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced e
65            Effective evaluation of human BAT stimulators is constrained by the current standard metho
66 NF family (BAFF), also known as B lymphocyte stimulator, is a ligand required for the generation and
67 KAP protein, MDI that recruits a translation stimulator, La-related protein (Larp), to the mitochondr
68  of intracellular ICOSL (inducible T-cell co-stimulator ligand, also known as ICOSLG) to the B-cell s
69 iogenesis-targeting moieties with angiogenic stimulator-loaded NPs could be incorporated into effecti
70                      The miniaturized neural stimulator may facilitate closed-loop neurostimulation f
71                                 Inducible co-stimulator molecule (ICOS) and HLA-DR were used to defin
72 ensive mutational analysis of the frameshift stimulators (mRNA signals and 2A protein) analysing acti
73                         CD40 is an important stimulator of autophagy and autophagic killing of Toxopl
74 ignificantly higher levels of IL-5, a potent stimulator of B-1 cell Ab production.
75 oxy-9Z-octadecenoic acid (12,13-diHOME) is a stimulator of BAT activity, and that its levels are nega
76                             Cold is a potent stimulator of BAT, activating BAT primarily through the
77 suggest that the RSPO family is an important stimulator of beta-catenin activity in many human tumors
78 d HDAC5, whereas PTH stimulation of RANKL, a stimulator of bone resorption, requires CRTC2.
79      Surprisingly, JWU-A021 is also a potent stimulator of Ca(2+) influx through TRPA1 cation channel
80 sab (cfos) as a potent miR-101a target gene, stimulator of CM proliferation, and inhibitor of scar ti
81   From these studies, we identify RAD18 as a stimulator of CRISPR-mediated HDR.
82 ogue of C-type natriuretic peptide, a potent stimulator of endochondral ossification.
83        The IAA/DNP combination is a powerful stimulator of exosome secretion, and these stimulatory e
84 entifies JWU-A021 to be an especially potent stimulator of glucagon-like peptide-1 (GLP-1) secretion
85                           As the most potent stimulator of GnRH/LH release, kisspeptin is believed to
86 g cyclic GMP-AMP (cGAMP) synthase (cGAS) and stimulator of IFN gene (STING) in human pDCs.
87  mammalian cells, cytosolic CDNs bind STING (stimulator of IFN gene), resulting in the production of
88 nd leads to activation of the cGAMP synthase-stimulator of IFN genes (cGAS-STING) pathway, independen
89                  The cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway detects cyt
90 nced tumors but can be up-regulated by local stimulator of IFN genes (STING) activation.
91 We have also demonstrated that codelivery of stimulator of IFN genes (STING) agonists stimulates immu
92 sor, cyclic GMP-AMP synthase (cGAS), and the stimulator of IFN genes (STING) are required for pathoge
93                                     With the stimulator of IFN genes (STING) C terminus being extensi
94  deficiencies in IFN-alpha/beta signaling or stimulator of IFN genes (STING) exhibit exacerbated neur
95                                              STimulator of IFN Genes (STING) has been identified as a
96  discovered that the innate immune regulator stimulator of IFN genes (STING) is completely silenced i
97 lammasome, on the functional output from the stimulator of IFN genes (STING) pathway is poorly unders
98 ed by the cyclic GMP-AMP synthase (cGAS) and stimulator of IFN genes (STING) pathway to induce type I
99                                     As such, stimulator of IFN genes (STING), an adaptor molecule inv
100 d autophagy via the cytoplasmic DNA receptor stimulator of IFN genes (STING), as well as fusion of ph
101 ger cGAMP, which in turn binds and activates stimulator of IFN genes (STING), leading to induction of
102 ng pathways triggered by B. abortus involves stimulator of IFN genes (STING), which leads to producti
103 rucella abortus DNA involves TLR9, AIM2, and stimulator of IFN genes (STING).
104  These secondary messengers bind directly to stimulator of IFN genes (STING).
105  synthase and the downstream adaptor protein stimulator of IFN genes (STING).
106 2, and Mincle), and the cytosolic DNA sensor stimulator of IFN genes (STING).
107 vation of the downstream signaling effectors stimulator of IFN genes and NF-kappaB, but not TANK-bind
108 dency on IFI16, cyclic GMP-AMP synthase, and stimulator of IFN genes for type I IFN induction by a pa
109  analyses have revealed a major role for the stimulator of IFN genes pathway (STING pathway), which s
110                                          The stimulator of IFN genes pathway was discovered to be a p
111 oposed to act in the cyclic GMP-AMP synthase-stimulator of IFN genes pathway.
112 al-signaling protein (MAVS) and mice lacking stimulator of IFN genes protein (STING), 2 downstream se
113 pendent on cytosolic DNA sensing mediated by stimulator of IFN genes signaling.
114                  The adaptor proteins STING (stimulator of IFN genes), MAVS (mitochondrial antiviral
115  and colleagues report on the role of STING (stimulator of IFN genes, TMEM173) in regulating critical
116 intracellular DNA triggers activation of the stimulator of IFN genes-dependent IFN-stimulatory DNA (I
117 , ADAM17, and the antiviral adaptor protein, stimulator of IFN genes.
118  an enhancer of GSIS in vivo and as a direct stimulator of insulin-independent glucose uptake is not
119                                          The stimulator of interferon (IFN) genes (STING) is a broad
120 Activation of the cyclic dinucleotide sensor stimulator of interferon (IFN) genes (STING) is critical
121 g the cyclic GMP-AMP synthase (cGAS) and the stimulator of interferon (IFN) genes (STING), two crucia
122 3'-cGAMP can bind the adaptor protein STING (stimulator of interferon [IFN] genes) to activate the pr
123 on and activation of cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) in APCs, res
124 mage response (DDR), cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway acti
125 tudy, we studied the cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway by u
126 of interferon-mediated antiviral responses - stimulator of interferon genes (STING) - has now emerged
127 -I) response by sequestering and attenuating stimulator of interferon genes (STING) activation.
128 dermines host antiviral responses, including stimulator of interferon genes (STING) activation.
129                                              Stimulator of interferon genes (STING) acts as a cytopla
130 he innate immune response that activates the stimulator of interferon genes (STING) adaptor and induc
131 the production of type I interferons via the stimulator of interferon genes (STING) adaptor.
132                    Furthermore, by loading a stimulator of interferon genes (STING) agonist, hNVs lea
133 gers both the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) and Toll-like rec
134        Cyclic dinucleotide (CDN) agonists of stimulator of interferon genes (STING) are a promising c
135                            Activation of the STimulator of INterferon Genes (STING) by DMXAA (5,6-dim
136  chromatin fragments and then activating the stimulator of interferon genes (STING) cytosolic DNA-sen
137 ctive puncta that promote lysosomal-mediated stimulator of interferon genes (STING) degradation.
138 apamycin (mTOR) to prevent the activation of stimulator of interferon genes (STING) expression and im
139                             The host protein Stimulator of Interferon Genes (STING) has been shown to
140                                              Stimulator of interferon genes (STING) has been shown to
141                                              Stimulator of interferon genes (STING) is a key cytosoli
142                                              Stimulator of interferon genes (STING) is a receptor in
143                                              Stimulator of interferon genes (STING) is an endoplasmic
144                                              Stimulator of interferon genes (STING) is essential for
145                                              Stimulator of interferon genes (STING) is known be invol
146 dominant gain-of-function mutations in human stimulator of interferon genes (STING) lead to a severe
147                                              Stimulator of interferon genes (STING) links innate immu
148 e modulators consisting of an agonist of the stimulator of interferon genes (STING) pathway and an ag
149                            Activation of the stimulator of interferon genes (STING) pathway can enhan
150        Since its discovery 12 years ago, the stimulator of interferon genes (STING) pathway has attra
151  evidence indicates the critical role of the stimulator of interferon genes (STING) pathway in antitu
152 ed interferon signaling mediated by the cGAS-stimulator of interferon genes (STING) pathway in patien
153                                          The Stimulator of Interferon Genes (STING) pathway initiates
154                                          The stimulator of interferon genes (STING) pathway plays an
155  activate the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway to induce
156 ctivating the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway(3).
157 enting cell maturation via the intracellular stimulator of interferon genes (STING) pathway, rather t
158 engers in the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, which pl
159 econd messenger that activates the antiviral stimulator of interferon genes (STING) pathway.
160 sponse to cytosolic dsDNA that activates the stimulator of interferon genes (STING) pathway.
161 vation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway.
162 ctively hyperresponsive to activators of the stimulator of interferon genes (STING) protein-a key reg
163 A and produces cGAMP, which in turn binds to stimulator of interferon genes (STING) to activate IFN-I
164                        Cytosolic DNA engages stimulator of interferon genes (STING) to activate TANK-
165 messenger that activates the adaptor protein stimulator of interferon genes (STING) to induce type I
166 a is a vita-PAMP, engaging the innate sensor stimulator of interferon genes (STING) to mediate endopl
167 transmembrane protein 173 (TMEM173) encoding stimulator of interferon genes (STING) underlie a recent
168                                              Stimulator of interferon genes (STING) was initially des
169 second messenger that binds to and activates stimulator of interferon genes (STING)(3-9).
170 P and prevent the activation of the receptor stimulator of interferon genes (STING)(5-7).
171    Here, we report that a natural agonist of stimulator of interferon genes (STING), 2'3'- cyclic gua
172  GMP-AMP (cGAMP), which binds to the adaptor STIMULATOR OF INTERFERON GENES (STING), activating an IN
173 response by oxidizing Cysteine 147 on murine stimulator of interferon genes (STING), an ER-associated
174 ways, such as cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING), and propagation
175 cGAS) and its downstream signalling effector stimulator of interferon genes (STING), as well as the m
176                  This effect is dependent on stimulator of interferon genes (STING), but not the Toll
177 pon activation, which binds to and activates stimulator of interferon genes (STING), leading to IFN p
178 endent upon the DNA-sensing pathway adaptor, stimulator of interferon genes (STING), through the reco
179 ome-like signaling events, driven in part by stimulator of interferon genes (STING), to unexpectedly
180                              cGAMP activates stimulator of interferon genes (STING), which activates
181 o responders to anti-CD47 immunotherapy in a stimulator of interferon genes (STING)- and interferon-d
182                                Patients with stimulator of interferon genes (STING)-associated vascul
183 gh mitosis or loss of pattern recognition by stimulator of interferon genes (STING)-cGAS impaired int
184 , as well as induction of AIM2-dependent and stimulator of interferon genes (STING)-dependent autopha
185 d to down-regulate the NF-kappaB pathway and stimulator of interferon genes (STING)-dependent cytokin
186  exhibit antitumor immunity that occurs in a stimulator of interferon genes (STING)-dependent manner
187 vation of cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING).
188 c GMP-AMP (cGAMP), which binds and activates stimulator of interferon genes (STING).
189 g or the endoplasmic reticulum (ER) adapter, stimulator of interferon genes (STING).
190 cleotide cGAMP, followed by the induction of stimulator of interferon genes (STING).
191                                              Stimulator of interferon genes (STING, also known as MIT
192                   Given the integral role of stimulator of interferon genes (STING, TMEM173) in the i
193  GMP-AMP (cGAMP) that binds to and activates stimulator of interferon genes (STING; also known as TME
194  For example, a gain-of-function mutation in stimulator of interferon genes (STING; N153S) upregulate
195 rt on a cyclic GMP-AMP adjuvant, the natural stimulator of interferon genes agonist, providing eviden
196 olymer, PSC7A, can achieve activation of the stimulator of interferon genes and antigen delivery upon
197 n of DNA sensors cyclic GMP-AMP synthase and stimulator of interferon genes in wild-type (WT) mice.
198 diguanylate monophosphate, an agonist of the stimulator of interferon genes pathway, and monophosphor
199 or inhibitors of the cyclic GMP-AMP synthase/stimulator of interferon genes pathway, which recruited
200 protein 16 (IFI16) detect DNA and signal via stimulator of interferon genes protein (STING).
201 Mase2, and pro-aging/pro-inflammatory STING (Stimulator of interferon genes) gene expression without
202                                       STING (stimulator of interferon genes) is an important innate i
203                                       STING (STimulator of INterferon Genes) mediates protective cell
204 -cGAMP), the natural agonist of STING (i.e., stimulator of interferon genes) or after infection with
205 vate the cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes) pathway and engage the a
206 y, the CGAS (cyclic GMP-AMP synthase)-STING (stimulator of interferon genes) pathway mitigates activa
207 GAS-STING (cyclic GMP-AMP synthase linked to stimulator of interferon genes) pathway, leading both to
208  of the cytosolic DNA sensing adaptor STING (stimulator of interferon genes) play a critical role in
209     Pharmacological activation of the STING (stimulator of interferon genes)-controlled innate immune
210 gonist of the interferon gene inducer STING (stimulator of interferon genes).
211 ntiviral response via the DNA sensor, STING (stimulator of interferon genes).
212  TRIM29 induces K48-linked ubiquitination of Stimulator of interferon genes, a key adaptor in double-
213  a focus on complement, the adapter molecule Stimulator of Interferon Genes, natural killer cells, my
214 ng, as exemplified by the recently described stimulator of interferon genes-associated vasculopathy w
215 ic activation of the cyclic GMP-AMP synthase-stimulator of interferon genes-TANK-binding kinase-inter
216  vasoactive intestinal polypeptide, a potent stimulator of ion secretion classically produced by ente
217 is secreted by white cells only, is a potent stimulator of macrophage chemokinesis, whose activity is
218               Chlamydial LOS was also a poor stimulator of maturation of bone marrow-derived dendriti
219 cute exercise and identified VEGF-A as a key stimulator of Mdm2 phosphorylation on Ser(166) (p-Ser166
220         The photosensitizer is also a potent stimulator of P-glycoprotein (P-gp).
221 ere mimics the activity of a structured mRNA stimulator of PRF.
222 e signals; kisspeptin has emerged as a major stimulator of puberty, and makorin RING finger protein 3
223 embolic pulmonary hypertension, riociguat, a stimulator of soluble guanylate cyclase, has proven effi
224 e show that MCB-613, a potent small molecule stimulator of steroid receptor coactivators (SRCs) atten
225 lterations associated with activation of the stimulator of the cyclic GMP-AMP synthase interferon gen
226 ociated DYRK1A kinase has been reported as a stimulator of the developmentally important Hedgehog (Hh
227 envelope of most bacteria, and also a potent stimulator of the eukaryotic immune system.
228 otent epithelial proliferation and migration stimulator of the oral mucosa as a potential therapy to
229 e that binds to chromosomal DNA; ParB is the stimulator of the ParA ATPase and specifically binds to
230 s, suggests that IL-33 might be an important stimulator of tissue-localized loss of normal Treg cell
231                   Despite acting as a direct stimulator of transcription, histone butyrylation compet
232  The aim was to determine whether leucine, a stimulator of translation initiation and skeletal muscle
233 nstrate that Chi3l1 is a multifaceted immune stimulator of tumor progression and metastasis whose ela
234     Despite the classical role of IRF-7 as a stimulator of type I interferon (IFN) transcription, the
235 ically, downregulated expression of IL-33, a stimulator of type II innate lymphoid cells, in lung epi
236              However, their effect as direct stimulators of B lymphocytes has not been yet fully eluc
237 thylase TET1 is suppressed by cold and other stimulators of beige adipocyte thermogenesis.
238 Dietary lipids are one of the most effective stimulators of carotenoid absorption, but very limited d
239 tro, DLL4-deficient APCs were less efficient stimulators of CD4(+) T cell activation, metabolism, pro
240                     We hypothesized that, as stimulators of early origin activation, Fkh1 and Fkh2 ab
241  cysteine were examined as inhibitors and/or stimulators of fresh-cut potato browning.
242 oter activity of human KISS1 and TAC3, 2 key stimulators of GnRH secretion.
243 in an antigen-dependent manner became potent stimulators of localized antigen-specific inflammatory r
244      This identifies THs as potent endocrine stimulators of mitochondrial function in human epidermis
245      Isoforms 01 and 03 were the most potent stimulators of patients' T cells.
246 uvate (PEP), Pro, and Ala as the most potent stimulators of plant leaf R(N) Using metabolite combinat
247                                              Stimulators of soluble guanylate cyclase (sGC) enhance N
248 es with inhibitors of phosphodiesterase 5 or stimulators of soluble guanylyl cyclase rapidly enhanced
249  isolated from C3H/HeJ mice were less potent stimulators of T lymphocyte proliferation and TH1/TH17 p
250   Aha-type co-chaperones are the most potent stimulators of the Hsp90 ATPase activity but the relatio
251  (TLR-9) in endosomes and are well described stimulators of the innate and adaptive immune system.
252 tigens at their cell surface that are potent stimulators of the innate immune response, and yet the c
253                                              Stimulator-of-interferon genes (STING) is vital for sens
254 lial cells through the inhibition of RB1 and stimulator-of-interferon-genes (STING) to propagate cell
255 ngers of one hand, and a neutral-temperature stimulator on the middle finger, all three fingers feel
256 derwent an attempted sphenopalatine ganglion stimulator or sham stimulator placement procedure were i
257 ide the TMS coil, starting at 25% of maximum stimulator output (MSO) and increasing in steps of 2% un
258 cy MST (i.e., 25 Hz MST) (N = 36) using 100% stimulator output.
259 atment of rats with the first-in-class NAMPT stimulator, P7C3-A20, prevented behavioral and histologi
260 engerRNAs, proteins, metabolites and various stimulators participating in regulatory networks.
261 aluated, including soluble guanylate cyclase stimulators, phosphodiesterase type 5 inhibitors, sodium
262  laparoscopy and connected to a dual-channel stimulator placed subcutaneously.
263 d sphenopalatine ganglion stimulator or sham stimulator placement procedure were included in the safe
264 ntagonist SCH 23390, but the infusion of PKC stimulator PMA does not.
265 lying the antiinflammatory effect of the sGC stimulator praliciguat (PRL) in the liver.
266 ts with HFpEF, the soluble guanylate cyclase stimulator praliciguat, compared with placebo, did not s
267 rase-5 inhibitors, soluble guanylate cyclase stimulators, prostacyclin analogues, and prostacyclin re
268              We demonstrate that wireless ME stimulators provide therapeutic deep brain stimulation i
269                                    Autophagy stimulator rapamycin reversed sesamol-induced apoptosis
270            Expression levels of B lymphocyte stimulator receptor 3 and programmed cell death 1 on B c
271  and vericiguat, a soluble guanylate cyclase stimulator, reduces heart failure hospitalization in hig
272 polysaccharide (LPS) is a toxic inflammatory stimulator released from the outer cell membrane of Gram
273 rst-in-class soluble guanylate cyclase (sGC) stimulator riociguat was recently introduced as a novel
274 were receiving the soluble guanylate cyclase stimulator riociguat.
275 rally involve single ribosomes responding to stimulator sequences in their engaged mRNAs.
276   Small GTP-binding protein GDP-dissociation stimulator (SmgGDS) proteins are chaperones that bind an
277                                 However, few stimulator solutions simultaneously offer high spatio-te
278 dditionally, the hippocampal infusion of PKA stimulator Sp-cAMP reverts the effect of D1/D5 dopaminer
279 ey T helper 17 (T(H)17) cell differentiation stimulator, STAT3(3,4), is subject to reversible S-palmi
280 an anti-parasite response via the interferon stimulator STING.
281  clathrin-coated pits and that physiological stimulators such as GPCR ligands induce ADAM17-mediated
282  the middle digit was lifted off the thermal stimulator, suggesting that tactile stimulation is neces
283 ion of TCR/CD3 genes, T cell co-receptors/co-stimulators, T cell activation and signal-transduction g
284             Furthermore, typical therapeutic stimulators target large nerve bundles that innervate mu
285 leadless and battery-free implantable neural stimulator that is 1.7 mm(3) and that incorporates a pie
286 e approaches have yet to produce a miniature stimulator that operates at clinically relevant high fre
287               Here, we employed a mechanical stimulator that reliably positioned animals' hands in di
288 nables miniature magnetically powered neural stimulators that operate up to clinically relevant frequ
289 hether stimulation occurs are encoded by the stimulator through backscatter modulation and are demodu
290              Here we show NLRP3 inflammasome stimulators trigger Src homology-2 domain containing pro
291 resulting in the discovery of once daily sGC stimulator vericiguat (compound 24, BAY 1021189), curren
292  Reduced Ejection Fraction) trial on the sGC stimulator vericiguat in HFrEF, the main open questions
293 uate the Efficacy and Safety of the Oral sGC Stimulator Vericiguat to Improve Physical Functioning in
294 ty of a novel oral soluble guanylate cyclase stimulator, vericiguat, on quality of life and exercise
295                  Covalent attachments to the stimulator were also identified in bacterial homologs of
296 on sensors, pressure sensors, and electrical stimulators, which are made via spray printing of silver
297                     Praliciguat, an oral sGC stimulator with extensive distribution to the liver, was
298 a hand-held external transceiver provide the stimulator with power and bidirectional communication.
299  Here, we present a flexible, spatial visual stimulator with up to six arbitrary spectrum chromatic c
300                      NO and the sGC-specific stimulator YC-1 induce a 71 degrees rotation of the heme

 
Page Top